97 related articles for article (PubMed ID: 21109938)
21. Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells.
Park JH; Liu L; Kim IH; Kim JH; You KR; Kim DG
Cancer Res; 2005 Apr; 65(7):2804-14. PubMed ID: 15805281
[TBL] [Abstract][Full Text] [Related]
22. [The inhibition effect and its molecular mechanism of human cervical cancer oncogene siRNA on hepatocarcinoma cells].
Yang Y; Zhou XF; Liu AD
Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):612-5. PubMed ID: 18752750
[TBL] [Abstract][Full Text] [Related]
23. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
24. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
[TBL] [Abstract][Full Text] [Related]
25. [Effect of siRNA-mediated inhibition of nuclear transcription factor-kappa B on apoptosis of hepatocarcinoma cells].
Wang YL; Yao DF; Wu W; Sai WL; Qiu LW; Yang JL; Zhu JW
Zhonghua Gan Zang Bing Za Zhi; 2010 Aug; 18(8):609-13. PubMed ID: 20825717
[TBL] [Abstract][Full Text] [Related]
26. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
[TBL] [Abstract][Full Text] [Related]
27. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic loss of CDH1 correlates with multidrug resistance in human hepatocellular carcinoma cells.
Jiang L; Chan JY; Fung KP
Biochem Biophys Res Commun; 2012 Jun; 422(4):739-44. PubMed ID: 22634315
[TBL] [Abstract][Full Text] [Related]
29. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2].
Xu KS; Wang HF; Qian W; Wang BH
Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364
[TBL] [Abstract][Full Text] [Related]
30. [Effect of p21-targeted shRNA on curcumin-induced apoptosis of human hepatoma Huh7 cells].
Wang WZ; Zhang BY; Mei WJ; Mao JW; Li M
Yao Xue Xue Bao; 2009 Oct; 44(10):1102-6. PubMed ID: 20055131
[TBL] [Abstract][Full Text] [Related]
31. [Effects of ARNT2 gene on invasion and migration of human hepatocellular carcinoma HCCLM6 cell line].
Li WW; Wu WZ; Liang Y; Xiao CL; Tao ZH; Wang L; Sun HC; Fan J
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):27-31. PubMed ID: 20128965
[TBL] [Abstract][Full Text] [Related]
32. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
33. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.
Castillo J; Erroba E; Perugorría MJ; Santamaría M; Lee DC; Prieto J; Avila MA; Berasain C
Cancer Res; 2006 Jun; 66(12):6129-38. PubMed ID: 16778186
[TBL] [Abstract][Full Text] [Related]
34. Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2.
Guo R; Wang T; Shen H; Ge HM; Sun J; Huang ZH; Shu YQ
Biomed Pharmacother; 2010 Apr; 64(4):249-53. PubMed ID: 19931998
[TBL] [Abstract][Full Text] [Related]
35. Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma.
Al-Rawashdeh FY; Scriven P; Cameron IC; Vergani PV; Wyld L
Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1099-105. PubMed ID: 20177386
[TBL] [Abstract][Full Text] [Related]
36. [The inhibitory effect of RNA interference on STAT3 expression in liver cancer cell line SMMC7721].
Liao WJ; Mei MH; Qin LL; Chen Q; Yuan SG; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):615-7. PubMed ID: 21651859
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
[TBL] [Abstract][Full Text] [Related]
38. A methyl jasmonate derivative, J-7, induces apoptosis in human hepatocarcinoma Hep3B cells in vitro.
Park C; Jin CY; Kim GY; Cheong J; Jung JH; Yoo YH; Choi YH
Toxicol In Vitro; 2010 Oct; 24(7):1920-6. PubMed ID: 20696234
[TBL] [Abstract][Full Text] [Related]
39. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
[TBL] [Abstract][Full Text] [Related]
40. [Suppression of SMYD3 expression in HepG2 cell by shRNA interference].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):105-8. PubMed ID: 16494778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
